Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 28 March 2019


How should we value the innovative cancer medicines that are transforming patient outcomes?

A blog by Nathalie Moll, EFPIA Director General

While our scientists, doctors and patients push the boundaries of medical science, it is crucial that we have evidence-based conversations about how to bring evidence-based medicines to those who need them.

A recent WHO technical report on the pricing of cancer medicines has sparked a lively debate on oncology spending and access to life-changing therapies. While we have fundamental concerns about the approach taken in the report, and the conclusions the authors reached, it offers opportunities for some fresh thinking on the future of cancer care. 

Read more




#ForTheChance to be confident (Guest blog)
18 March 2019

The story of Ayesha, living with cancer Read more




EFPIA Manifesto: Building a healthier future for Europe
We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there.Read more

For The Chance To...
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the... Read more




Connecting Healthcare - EFPIA 2019 Annual Conference
27 June 2019 (Radisson Blu Royal Hotel, Brussels, Belgium)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

WIN 2019 Symposium
23 June 2019 (Paris, France)

A symposium dedicated to Innovation and global deployment of Precision Oncology Read more

EU Pharmaceutical Law Forum
21 May 2019 (The Hotel Brussels, Brussels, Belgium)

Europe’s leading pharmaceutical law networking and knowledge hub on competition law, patent litigation, regulatory frameworks,... Read more

FT Digital Health Summit 2019
18 June 2019 (Berlin)

Collaboration is key to effectively harnessing digital disruption to ease the strain and deliver more adaptable and... Read more


What we are reading


20 years of sampling and testing programme for medicines authorised for the EU
On 28 March 2019 (European Medicines Agency)

EMA and the European Directorate for the Quality of Medicines & Healthcare (EDQM) have reviewed EMA’s sampling and... Read more

HARMONY Anonymization Concept Reconciles Data Quality, Safety, and Privacy
On 28 February 2019 (The HARMONY Alliance)

Data has the enormous potential to improve the health of patients around the world. Artificial intelligence (AI) systems... Read more